Edwards Lifesciences Corp
Edwards Lifesciences Corp/ US28176E1082 /
EW
09/10/2024 22:10:00
|
Chg.
-0.52
|
Volume |
Bid01:46:43 |
Ask01:46:43 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
68.02USD
|
-0.76%
|
4.74 mill. Turnover: 248.55 mill. |
67.55Bid Size: 100 |
68.48Ask Size: 100 |
40.98 bill.USD |
- |
29.45 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
2.31 USD |
-6.10% |
EPS Diluted: |
2.30 USD |
-5.74% |
Revenues per Share: |
9.99 USD |
12.86% |
Book Value per Share: |
11.17 USD |
17.07% |
Cash Flow per Share: |
1.49 USD |
-25.61% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
6,004.80 USD |
11.56% |
Net Income: |
1,402.40 USD |
-7.85% |
Operating Cash Flow: |
895.80 USD |
- |
Cash and Cash Equivalents: |
1,144.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
29.45 |
33.01 |
P/S Ratio: |
6.81 |
7.64 |
P/BV ratio: |
6.09 |
6.82 |
P/CF Ratio: |
45.66 |
51.18 |
PEG: |
-4.83 |
-5.41 |
Earnings Yield: |
3.40% |
3.03% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
40.98 bill. USD |
45.85 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
602.4 mill. |
|
Profitability
Gross Profit Margin: |
77.02% |
EBIT Margin: |
25.55% |
Net Profit Margin: |
23.35% |
Return on Equity: |
20.87% |
Return on Assets: |
14.98% |
Financial Strength
Liquidity I / Cash Ratio: |
95.70% |
Liquidity II / Quick Ratio: |
160.54% |
Liquidity III / Current Ratio: |
337.60% |
Debt / Equity Ratio: |
39.35% |
Dynam. Debt / Equity Ratio: |
295.13% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
US GAAP |